Together with Alberto Cairo, I presented at the Bloomberg Businessweek Design Conference (highlights) on the topic of design and communication in the sciences.
Alberto, as the journalist, motivated why communication should include access to detail through an engaging narrative. He made the distinction between the specialist (heavy on detail) and the communicator (focus on narrative) and emphasized that the distinction is artificial, though often played out (watch video).
I, as the scientist, underscored the importance of clear communication between scientists. As the specialists, they are often very poor communicators. Pick up any science journal and you'll quickly discover that scientists either aren't good at telling stories or are discouraged to do so by the medium. The consequence is the same: papers read like a wall of text. TL;DR anyone? The quality of visual communication in general ranges from muddled to abysmal (watch video).
We need more leaders in the field, such as Nature Publishing Group, to reward and emphasize good visual communication (e.g. Nature Cancer Review 2013 Figure Calendar).
Our presentations concluded with a 15 minute moderated discussion with Sam Grobart, senior Businesssweek writer. Everyone got a little cheeky. Good fun.
Watch: my presentation, conversation with Alberto Cairo, moderated by Sam Grobart. (Bloomberg TV), Albert Cairo's presentation.
This was a lightning 7 minute talk. I did more planning about what to say than I usually do, given that there was virtually no opportunity for any kind of backtracking, and include a running narrative below each slide.
My slides are available as PDF, keynote (zipped) or Quicktime. The format is 16:9 HD.
On 28 Jan 2013, Bloomberg Businessweek Design Issue will capture the ideas from the conference and the personalities that generated them.
During the conference, each talk was captured in a series of sketches by Tom Wujec: my talk sketch and moderated discussion sketch.
My cover design on the 7 April 2026 Nature Biotechnology issue shows the dendrogram that represents a cluster of uniquely expressed (or downregulated) genes in human naive stem cells induced from such cells. Within each dendrogram block, the genomic barcode sequence (sampled from Supplementary Table 1) is depicted with a Code 39 barcode. The highlighted barcode is one of those used for cell isolation.
Ishiguro S. et al. A multi-kingdom genetic barcoding system for precise clone isolation (2026) Nature Biotechnology 44:616–629.
Browse my gallery of cover designs.
Celebrate π Day (March 14th) and enjoy the art — but only if you're part of the 5%.
Go ahead, see what you can't see.
Authentic and accurate images of Ishihara's test plates photographed (and lovingly color-corrected) from the 38-plate Ishihara's Tests for Colour Deficiency.
I also provide the position, size, and color of each circle on each test plate.
What immortal hand or eye, could frame thy fearful symmetry? — William Blake, "The Tyger"
This month, we look at symmetric regression, which, unlike simple linear regression, it is reversible — remaining unaltered when the variables are swapped.
Simple linear regression can summarize the linear relationship between two variables `X` and `Y` — for example, when `Y` is considered the response (dependent) and `X` the predictor (independent) variable.
However, there are times when we are not interested (or able) to distinguish between dependent and independent variables — either because they have the same importance or the same role. This is where symmetric regression can help.
Luca Greco, George Luta, Martin Krzywinski & Naomi Altman (2025) Points of significance: Symmetric alternatives to the ordinary least squares regression. Nat. Methods 22:1610–1612.
Fuelled by philanthropy, findings into the workings of BRCA1 and BRCA2 genes have led to groundbreaking research and lifesaving innovations to care for families facing cancer.
This set of 100 one-of-a-kind prints explore the structure of these genes. Each artwork is unique — if you put them all together, you get the full sequence of the BRCA1 and BRCA2 proteins.